These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1786063)

  • 61. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population.
    Potter JM; McWhinney BC; Sampson L; Hickman PE
    Ther Drug Monit; 2004 Aug; 26(4):408-14. PubMed ID: 15257071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Metabolic differentiation of peripheral blood lymphocytes after kidney transplantation in relation to post-transplantation immuno- suppression in the light of the analysis of cellular activity of DNA transcription enzymes].
    Adamiec R; Szewczyk Z; Szopa J
    Pol Arch Med Wewn; 1991 Oct; 86(4):209-19. PubMed ID: 1813875
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical manifestations of acute rejection in renal allograft recipients receiving cyclosporin-A therapy.
    Chung YC; Lee PH; Chang CN; Hu RH; Lee CS
    J Formos Med Assoc; 1991 Apr; 90(4):375-81. PubMed ID: 1680967
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiac and vascular abnormalities in renal transplant patients: differential effects of cyclosporin and azathioprine.
    Galiatsou E; Morris ST; Jardine AG; Rodger RS; Watson MA; Elliott HL
    J Nephrol; 2000; 13(3):185-92. PubMed ID: 10928294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of azathioprine reduction in late renal allograft failure.
    Parfrey PS; Hutchinson TA; Lowry RP; Knaack J; Guttmann RD
    Transplantation; 1985 Feb; 39(2):147-51. PubMed ID: 3881853
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Doppler spectrum analysis in the differential diagnosis of renal transplant dysfunction.
    Merkus JW; van Asten WN; Hoitsma AJ; van't Hof MA; Koene RA; Skotnicki SH
    Clin Transplant; 1996 Oct; 10(5):420-8. PubMed ID: 8930455
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tear flow in cyclosporine recipients.
    Palmer SL; Bowen PA; Green K
    Ophthalmology; 1995 Jan; 102(1):118-21. PubMed ID: 7831025
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation.
    MacPhee IA; Bradley JA; Briggs JD; Junor BJ; MacPherson SG; McMillan MA; Rodger RS; Watson MA
    Transplantation; 1998 Nov; 66(9):1186-92. PubMed ID: 9825816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term renal function in heart transplant recipients receiving cyclosporine therapy.
    Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK
    J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation.
    Thistlethwaite JR; Haag BW; Jones KW; Stuart JK; Stuart FP
    Hum Immunol; 1985 Nov; 14(3):314-23. PubMed ID: 3902749
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Cyclosporin A in preventive therapy after kidney transplantation: a double combination versus a triple combination. I. Therapeutic effectiveness].
    Matl I; Jirka J; Kocandrle V; Petrásek R
    Cas Lek Cesk; 1990 May; 129(18):550-3. PubMed ID: 2350773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safe conversion from cyclosporine to azathioprine with improved renal function in pediatric renal transplantation.
    Kaiser BA; Lawless ST; Palmer JM; Dunn SP; Polinsky MS; Baluarte HJ
    Pediatr Nephrol; 1989 Oct; 3(4):401-5. PubMed ID: 2642107
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Late kidney rejection: influence of imbalance in prednisone and azathioprine dosages].
    Chocair PR; Galvão MM; Soares DC; Ianhez LE; Sabbaga E
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Oct; 33(5):243-7. PubMed ID: 368947
    [No Abstract]   [Full Text] [Related]  

  • 77. A comparison of triple-therapy with double-therapy immunosuppression in cadaveric renal transplantation.
    Bowman JS; Angstadt JD; Waymack JP; Jaffers GJ
    Transplantation; 1992 Mar; 53(3):556-9. PubMed ID: 1312752
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.
    Sinclair NR
    CMAJ; 1992 Sep; 147(5):645-57. PubMed ID: 1521210
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression.
    Petrakopoulou P; Anthopoulou L; Muscholl M; Klauss V; von Scheidt W; Uberfuhr P; Meiser BM; Reichart B; Weis M
    J Am Coll Cardiol; 2006 Apr; 47(8):1622-9. PubMed ID: 16631000
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
    Hardy KW; Crocker JF; McLellan H; Goralski KB; Renton KW; Acott PD
    J Clin Pharmacol; 2005 Feb; 45(2):161-7. PubMed ID: 15647408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.